Vanberra Signal
Free trial

Drug Design Methodologies

Curated by Signal

Provider of drug design methodologies with a focus on ligand refinement software

Health Technologynewdrugdesign.com

Overview

Provider of drug design methodologies with a focus on ligand refinement software. The company offer software RACHEL, aims to improve ligand-receptor binding interactions for pharmaceutical manufacturing purposes. It also engage in machine learning models to uncover new drug design opportunities in the ever-adapting world of pathogens.

Key facts

Founded
1998
Headquarters
St. Louis, United States
Stage
Sign up to view
Industry
Health Technology

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Greenpot MD

    Provider of medical marijuana card based on doctor consultation

    Health TechnologyWashington, DC, United States

  • CAREnQ

    Online video consultations for urgent care

    Health TechnologyMilwaukee, United States

  • BEST COSMETIC HOSPITALS

    Online platform to search and book hospitals for cosmetic surgery

    Health TechnologyNew York City, United States

About Drug Design Methodologies

What does Drug Design Methodologies do?

Provider of drug design methodologies with a focus on ligand refinement software.

Where is Drug Design Methodologies headquartered?

Drug Design Methodologies is headquartered in St. Louis, United States.

When was Drug Design Methodologies founded?

Drug Design Methodologies was founded in 1998.

Which sector is Drug Design Methodologies in?

Drug Design Methodologies operates in Health Technology.

Who are Drug Design Methodologies's competitors?

Companies similar to Drug Design Methodologies include Greenpot MD, CAREnQ, and BEST COSMETIC HOSPITALS.